Los puntos clave no están disponibles para este artículo en este momento.
The olanzapine/fluoxetine combination did not differ significantly from the other therapies at endpoint, although it demonstrated a more rapid response that was sustained until the end of treatment. The results raised several methodological questions, and recommendations are made regarding the criteria for study entry and randomization.
Shelton et al. (Sat,) studied this question.